Isolation, Biochemical and Molecular Identification, and In-Vitro Antimicrobial Resistance Patterns of Bacteria Isolated from Bubaline Subclinical Mastitis in South India

PLoS One. 2015 Nov 20;10(11):e0142717. doi: 10.1371/journal.pone.0142717. eCollection 2015.

Abstract

Buffaloes are the second largest source of milk. Mastitis is a major impediment for milk production, but not much information is available about bubaline mastitis, especially subclinical mastitis. The aim of this study was to (a) investigate the application of various tests for the diagnosis of bubaline subclinical mastitis, (b) identify the major bacteria associated with it, and (c) evaluate the antibiotic resistance pattern of the bacteria. To this end, 190 quarter milk samples were collected from 57 domesticated dairy buffaloes from organized (64 samples) and unorganized (126 samples) sectors. Of these, 48.4%, 40.0%, 45.8%, 61.1%, and 61.6% were positive for subclinical mastitis by somatic cell count, electrical conductivity, California mastitis test, bromothymol blue test, and N-acetyl glucosaminidase test, respectively. As compared to the gold standard of somatic cell count, California mastitis test performed the best. However, a combination of the two methods was found to be the best option. Microbiological evaluation, both by biochemical methods as well as by monoplex and multiplex polymerase chain reaction, revealed that coagulase-negative staphylococci were the most predominant (64.8%) bacteria, followed by streptococci (18.1%), Escherichia coli (9.8%) and Staphylococcus aureus (7.3%). Most of the pathogens were resistant to multiple antibiotics, especially to β-lactam antibiotics. We propose that California mastitis test be combined with somatic cell count for diagnosis of subclinical mastitis in domestic dairy buffaloes. Further, our results reveal high resistance of the associated bacteria to the β-lactam class of antibiotics, and a possible major role of coagulase-negative staphylococci in causing the disease in India.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Infective Agents / therapeutic use
  • Buffaloes / microbiology*
  • Cattle
  • Escherichia coli / isolation & purification
  • Escherichia coli / pathogenicity
  • Female
  • Humans
  • India
  • Mastitis, Bovine / drug therapy
  • Mastitis, Bovine / genetics
  • Mastitis, Bovine / microbiology*
  • Milk / microbiology*
  • Staphylococcus / isolation & purification*
  • Staphylococcus / pathogenicity
  • Streptococcus / isolation & purification*
  • Streptococcus / pathogenicity
  • beta-Lactam Resistance

Substances

  • Anti-Infective Agents

Grants and funding

This work was funded in part by a grant from the Department of Biotechnology (BT/Indo-US/04/06/2009), Government of India (www.dbtindia.nic.in), to NRH and SI, and from the Department of Innovation, Industry, Science and Research (BF040038), Government of Australia (www.industry.gov.au), to TKM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.